Importantly, immunohistochemistry assay in UBUC patients reconfirmed high correlation between tumor stage and pFOXO3(S294) (MAP2K1/2 substrate) as well as tumor stage and pFOXO3(S253) (AKT1 substrate) protein level. This evidence concerns the gene MAP2K1 and neoplasm.